Showing results (11-20 of 361) with videos related to
Sort By:
Pageof 37
Bone|November 4, 2017
Variable signaling activity by FOP ACVR1 mutationsJulia Haupt, Meiqi Xu, Eileen M ShoreDrug Discovery Today. Therapeutic Strategies|April 20, 2013
When one skeleton is enough: approaches and strategies for the treatment of fibrodysplasia ossificans progressiva (FOP)Frederick S Kaplan, Jay Groppe, Eileen M ShoreBiomedicines|April 27, 2024
Cellular and Molecular Mechanisms of Heterotopic Ossification in Fibrodysplasia Ossificans ProgressivaLoreilys Mejias Rivera, Eileen M Shore, Foteini MourkiotiOrphanet Journal of Rare Diseases|December 3, 2011
Fibrodysplasia ossificans progressiva: clinical and genetic aspectsRobert J Pignolo, Eileen M Shore, Frederick S KaplanDisease Models & Mechanisms|November 2, 2012
Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosisFrederick S Kaplan, Salin A Chakkalakal, Eileen M ShoreTrends in Molecular Medicine|September 19, 2024
Fibrodysplasia ossificans progressiva emerges from obscurityFrederick S Kaplan, Eileen M Shore, Robert J PignoloSeminars in Cell & Developmental Biology|December 27, 2015
Granting immunity to FOP and catching heterotopic ossification in the ActFrederick S Kaplan, Robert J Pignolo, Eileen M ShoreFrontiers in Cell and Developmental Biology|December 28, 2020
The Developmental Phenotype of the Great Toe in Fibrodysplasia Ossificans ProgressivaO Will Towler, Frederick S Kaplan, Eileen M ShoreClinical Orthopaedics and Related Research|June 19, 2007
Functional modeling of the ACVR1 (R206H) mutation in FOPJay C Groppe, Eileen M Shore, Frederick S KaplanCytokine & Growth Factor Reviews|November 10, 2009
The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signalingFrederick S Kaplan, Robert J Pignolo, Eileen M ShorePageof 37